Table 2. Effects of antrodan on various body and organ weights.1 , 2 .
Parameter | Control | LPS | Antrodan | Antrodan L+ LPS | Antrodan H + LPS |
Body weight (g) | |||||
Initial | 260.50±8.35a | 263.40±7.60a | 260.25±10.37a | 262.6±13.48a | 260.0±12.39a |
Final | 310.12±6.76a | 314.25±9.00a | 308.25±17.27a | 305.0±20.68a | 304.5±20.4a |
Liver weight (g) | 10.75±1.65b | 10.83±1.42b | 11.15±1.43b | 11.70±0.80a | 11.32±1.13b |
Liver to body weight (%) | 3.75±0.54ab | 3.44±0.43b | 3.69±0.29ab | 3.85±0.33a | 3.73±0.45a |
LPS, 5 mg/kg lipopolysaccharide; Antrodan, antrodan control at 40 mg/kg; Antrodan L, 40 mg/kg + LPS; Antrodan H, 80 mg/kg + LPS.
Values are expressed as mean ± S.D. (n = 6). Within the same row, different superscripts indicate significant differences between treatments (p<0.05) by using one way ANOVA followed by the post-hoc LSD test.